Tyo, K.M.; Minooei, F.; Curry, K.C.; NeCamp, S.M.; Graves, D.L.; Fried, J.R.; Steinbach-Rankins, J.M.
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications. Pharmaceutics 2019, 11, 160.
https://doi.org/10.3390/pharmaceutics11040160
AMA Style
Tyo KM, Minooei F, Curry KC, NeCamp SM, Graves DL, Fried JR, Steinbach-Rankins JM.
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications. Pharmaceutics. 2019; 11(4):160.
https://doi.org/10.3390/pharmaceutics11040160
Chicago/Turabian Style
Tyo, Kevin M., Farnaz Minooei, Keegan C. Curry, Sarah M. NeCamp, Danielle L. Graves, Joel R. Fried, and Jill M. Steinbach-Rankins.
2019. "Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications" Pharmaceutics 11, no. 4: 160.
https://doi.org/10.3390/pharmaceutics11040160
APA Style
Tyo, K. M., Minooei, F., Curry, K. C., NeCamp, S. M., Graves, D. L., Fried, J. R., & Steinbach-Rankins, J. M.
(2019). Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications. Pharmaceutics, 11(4), 160.
https://doi.org/10.3390/pharmaceutics11040160